Hubungan Nuliparitas Terhadap Kejadian Preeklampsia dengan Penyulit di Rumah Sakit Rujukan Tersier

Jojor Sihotang, Darma Lutfi Ananda, Renardy Reza Razali, Sri Wahyuni

Abstract

Maternal Mortality Rate (MMR) remains high globally, particularly in developing countries. In Indonesia, hypertensive disorders of pregnancy, including preeclampsia, are major contributors to maternal mortality. The prevalence of preeclampsia at Arifin Achmad Regional General Hospital was 28.12%. Nulliparity is a known risk factor for preeclampsia; however, no studies have examined its association with complicated preeclampsia in Riau Province. This study aimed to analyze the relationship between nulliparity and the occurrence of complicated preeclampsia. This observational analytic study employed a retrospective cross-sectional design using secondary data from medical records of preeclampsia patients at Arifin Achmad Regional General Hospital, Riau Province, from 2019 to 2022. Consecutive sampling was applied to include all patients meeting the inclusion and exclusion criteria. Data were analyzed using Fisher’s exact test. Out of 1,861 pregnant women, 361 (19.4%) developed preeclampsia. A total of 344 patients met the inclusion criteria, of whom 292 (84.9%) had complicated preeclampsia. Based on parity, 95 (32.5%) were nulliparous and 197 (67.5%) were multiparous. Fisher’s exact test showed no significant association between nulliparity and the occurrence of complicated preeclampsia (p = 1.000; OR = 1.007; 95% CI: 0.537–1.889). There was no significant association between nulliparity and the occurrence of complicated preeclampsia at Arifin Achmad Regional General Hospital during the 2019–2022 period.

Keywords

Preeclampsia; Nulliparity; Maternal Health; Retrospective Study

References

WHO. February 2023 [Internet]. [cited 2023 Oct 10]. Maternal mortality. Available from: https://data.unicef.org/topic/maternal-health/maternal-mortality/

Yang Y, Le Ray I, Zhu J, Zhang J, Hua J, Reilly M. Preeclampsia prevalence, risk factors, and pregnancy outcomes in Sweden and China. JAMA Netw Open. 2021;4(5):1–14. doi:10.1001/jamanetworkopen.2021.8401 PubMed PMID: 33970258.

Gemechu KS, Assefa N, Mengistie B. Prevalence of hypertensive disorders of pregnancy and pregnancy outcomes in Sub-Saharan Africa: A systematic review and meta-analysis. Women’s Health. SAGE Publications Ltd; 2020. doi:10.1177/1745506520973105 PubMed PMID: 33334273.

Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222. Obstetrics and Gynecology. 2020 Jun 1;135(6):E237–60. doi:10.1097/AOG.0000000000003891 PubMed PMID: 32443079.

Fox R, Kitt J, Leeson P, Aye CYL, Lewandowski AJ. Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring. J Clin Med. 2019;8(10):1–22. doi:10.3390/jcm8101625 PubMed PMID: 31590294.

Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia pathophysiology and clinical presentations: JACC state of the art review. Journal of the American College of Cardiology. Elsevier Inc.; 2020. p. 1690–702. doi:10.1016/j.jacc.2020.08.014 PubMed PMID: 33004135.

Bdolah Y, Elchalal U, Natanson-Yaron S, Yechiam H, Bdolah-Abram T, Greenfield C, et al. Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertens Pregnancy. 2014 May 1;33(2):250–9. doi:10.3109/10641955.2013.858745

Chang KJ, Seow KM, Chen KH. Preeclampsia: Recent Advances in Predicting, Preventing, and Managing the Maternal and Fetal Life-Threatening Condition. International Journal of Environmental Research and Public Health. MDPI; 2023. doi:10.3390/ijerph20042994 PubMed PMID: 36833689.

Phipps EA, Thadhani R, Thomas Benzing SAK. Pre-eclampsia: pathogenesis, novel diagnostics and therapies Elizabeth. J Natl Med Assoc. 2019;15(5):275–89. doi:10.1038/s41581-019-0119-6.Pre-eclampsia PubMed PMID: 35654631.

Bartsch E, Medcalf KE, Park AL, Ray JG, Al-Rubaie ZTA, Askie LM, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: Systematic review and meta-analysis of large cohort studies. The BMJ. 2016 Apr 19;353. doi:10.1136/bmj.i1753 PubMed PMID: 27094586.

Karta Asmana S, Syahredi, Hilbertina N. Hubungan usia dan paritas dengan kejadian preeklampsia. Jurnal Kesehatan Andalas [Internet]. 2016;5(3). Available from: http://jurnal.fk.unand.ac.id

Espinoza J, Vidaeff A, Pettker CM, Simhan H. ACOG Practice bulletin clinical management guidelines for obstetrician-gynecologists [Internet]. 2020. Available from: http://journals.lww.com/greenjournal

Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension. Lippincott Williams and Wilkins; 2018. p. 24–43. doi:10.1161/HYPERTENSIONAHA.117.10803 PubMed PMID: 29899139.

Shen M, Smith GN, Rodger M, White RR, Walker MC, Wen SW. Comparison of risk factors and outcomes of gestational hypertension and pre-eclampsia. PLoS One. 2017 Apr 1;12(4). doi:10.1371/journal.pone.0175914 PubMed PMID: 28437461.

Rana S, Lemoine E, Granger J, Karumanchi SA. Preeclampsia: pathophysiology, challenges, and perspectives. Circ Res. 2019 Mar 29;124(7):1094–112. doi:10.1161/CIRCRESAHA.118.313276 PubMed PMID: 30920918.

Moreno IA, Rodríguez-Benitez P, Ruiz-Minaya M, Claverol MB, Abad VO, Martin CH, et al. Maternal perinatal characteristics in patients with severe preeclampsia: A case-control nested cohort study. Int J Environ Res Public Health. 2021 Nov 1;18(22). doi:10.3390/ijerph182211783 PubMed PMID: 34831539.

Kongwattanakul K, Saksiriwuttho P, Chaiyarach S, Thepsuthammarat K. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and hellp syndrome. Int J Womens Health. 2018;10:371–7. doi:10.2147/IJWH.S168569

DOI: https://doi.org/10.26891/JIK.v20i1.2026.65-70

Refbacks

  • There are currently no refbacks.